[ad_1]

Corindus Vascular Robotics, Inc. (NYSEAMERICAN:CVRS) Logo

The stock of Corindus Vascular Robotics Inc (de (NYSEAMERICAN:CVRS) registered a decrease of 5.03% in short interest. CVRS’s total short interest was 12.65M shares in May as published by FINRA. Its down 5.03% from 13.32M shares, reported previously. With 292,600 shares average volume, it will take short sellers 43 days to cover their CVRS’s short positions. The short interest to Corindus Vascular Robotics Inc (de’s float is 11.41%.

The stock decreased 0.46% or $0.01 during the last trading session, reaching $2.17. About 817,634 shares traded. Corindus Vascular Robotics, Inc. (NYSEAMERICAN:CVRS) has risen 50.50% since May 4, 2018 and is uptrending. It has outperformed by 46.13% the S&P500.

Corindus Vascular Robotics, Inc. designs, makes, and sells robotic-assisted precision vascular intervention systems for use in interventional vascular procedures. The company has market cap of $447.51 million. The firm offers CorPath system, a medical device with robotic-assisted precision for radial, coronary, and peripheral procedures. It currently has negative earnings. The Company’s CorPath system facilitates stent positioning for PCI procedures by allowing a physician to measure, manipulate, and advance devices with robotic precision; and CorPath GRX system enables the precise, robotic-assisted control of coronary guide catheters, guidewires, and balloon/stent devices from the safety of a radiation-shielded interventional cockpit.

More notable recent Corindus Vascular Robotics, Inc. (NYSEAMERICAN:CVRS) news were published by: Marketwatch.com which released: “Warren Buffett’s stock picks crush Carl Icahn’s so far in 2016 – MarketWatch” on February 26, 2016, also Streetinsider.com with their article: “Corindus Vascular Robotics (CVRS) Announces FDA Clearance for First Automated Robotic Movement in technIQ Series for CorPath GRX Platform – StreetInsider.com” published on March 05, 2018, Businesswire.com published: “Corindus Vascular Robotics Announces Closing of Private Placement for $15 Million – Business Wire” on February 26, 2019. More interesting news about Corindus Vascular Robotics, Inc. (NYSEAMERICAN:CVRS) were released by: Marketwatch.com and their article: “10 cheap energy stocks that could soar up to 202% – MarketWatch” published on February 14, 2015 as well as Streetinsider.com‘s news article titled: “Corindus Vascular Robotics (CVRS) Announces $25M Private Placement of Series A Convertible Preferred Shares, Warrants – StreetInsider.com” with publication date: March 16, 2018.

Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our FREE daily email newsletter.


[ad_2]

Source link